<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01990976</url>
  </required_header>
  <id_info>
    <org_study_id>1208050</org_study_id>
    <secondary_id>2012-A00430-43</secondary_id>
    <nct_id>NCT01990976</nct_id>
  </id_info>
  <brief_title>Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced.</brief_title>
  <acronym>FSHD3</acronym>
  <official_title>Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association Française contre les Myopathies (AFM), Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The safety of guided practice of physical activity in myopathies is increasingly accepted,
      including muscular dystrophies. In facioscapulohumeral dystrophy (FSHD), one of the most
      common muscular dystrophy, the aerobic training showed its physiological and functional
      efficiency without affecting the quality of life of patients. The issue of exercise therapy
      extended to all neuromuscular diseases, as has been rigorously analyzed, shows that the use
      of a training program combining endurance exercise targeted exercises and strength is even
      more relevant.

      To complete the multidimensional assessments be managed by each team ( physiological
      assessments, functional tissue and quality of life) it is relevant to continue , for a
      descriptive study quantitative and qualitative analyzes by muscle imaging and spectroscopy
      (MRI and Nuclear Resonance Imaging (NMR) spectroscopy ).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      These non-invasive assessments already in place at the time of the initial training (FSHD1
      study, NCT01116570) will be repeated in the medium (12 months) and long term (30 months) in
      the same laboratory NMR AIM - CEA , Institute of Myology in Paris (P Carlier ). The data
      obtained from NMR repeated examinations and those obtained from biochemical analyzes and
      additional muscle histomorphometric (cellular aging estimation of involution fibroadipose )
      on biopsies already programmed (initial, 6 months and 30 months, FSHD2 study, NCT01689480)
      will be respectively compared to initial time to follow the evolution food and energy
      capacity of trained muscles. The study of biopsies provide mechanistic arguments and
      morphometric specific cellular response to exercise, data will be advantageously complemented
      by NMR specialized examinations extended to all the muscles of the thigh (target of training
      ) and muscle quantification whole body MRI.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Parameters of MRI</measure>
    <time_frame>30 months</time_frame>
    <description>whole body imaging T1, T2-weighted</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle tissue parameters</measure>
    <time_frame>30 months</time_frame>
    <description>muscle biopsy</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Muscular Dystrophy</condition>
  <condition>Facioscapulohumeral</condition>
  <arm_group>
    <arm_group_label>FSHD training</arm_group_label>
    <description>Only the patients who have participated to the FSHD1 study (NCT01116570) and the FSHD2 study (NCT01689480) can be included in this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>In Paris centre, a total body NMR imaging will be done with standard T2- and T1-weighted images.</description>
    <arm_group_label>FSHD training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsy</intervention_name>
    <description>biopsy of the vastus lateralis muscle</description>
    <arm_group_label>FSHD training</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Muscles
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with facioscapulohumeral dystrophy and who have participated to the FSHD1 and FSHD2
        studies
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Included in the FSHD1 and FSHD2 studies

          -  Social Security regimen affiliated

          -  Consent form signed

        Exclusion Criteria:

          -  Severe cardiac or respiratory insufficiency

          -  Cardiac pacemaker

          -  Morbid obesity (BMI upper to 35)

          -  Anti platelet therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Léonard FEASSON, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint-Etienne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Grenbole</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Saint-Etienne</name>
      <address>
        <city>St Etienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2013</study_first_submitted>
  <study_first_submitted_qc>November 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2013</study_first_posted>
  <last_update_submitted>July 27, 2015</last_update_submitted>
  <last_update_submitted_qc>July 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Muscular Dystrophy</keyword>
  <keyword>Facioscapulohumeral</keyword>
  <keyword>Physical training</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Muscle Biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

